Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Central Signaling Pathway in Lymphoma Blocked Successfully

April 14, 2015 8:19 am | by University of Zurich | News | Comments

Cancer researchers from the University of Zurich have identified a key signaling pathway in B-cell lymphoma, a malignant type of blood cancer. Read more...

TOPICS:

Eisai, Genomics Plc to Team Up on Large Scale Genotype/Phenotype Data Analysis Project

April 14, 2015 8:18 am | News | Comments

Both companies believe that human genetics and genomics can add great value to the drug development process. Read more...

TOPICS:

NIH, South African Medical Research Council Award $8M in HIV, TB Grants

April 14, 2015 8:17 am | by National Institutes of Health | News | Comments

The National Institutes of Health and the South African Medical Research Council (SAMRC) are awarding 31 grants to U.S. and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers. Read more...

TOPICS:
Advertisement

New Way to Fight Cancer

April 14, 2015 8:17 am | by Harvard University | News | Comments

Targeted cancer therapies work by blocking a single oncogenic pathway to halt tumor growth. Read more...

TOPICS:

Coffee Protects DNA From Breaking, Say Two Recent Studies

April 13, 2015 3:47 pm | by Drug Discovery & Development Staff | Articles | Comments

Coffee drinking is often associated with lower rates of degenerative diseases, from Parkinson’s to cancers. Two recent studies support one theory why: coffee protects DNA from breaking, and quite shortly after it is consumed.

TOPICS:

Sanofi Executive: No Need to Discount New Diabetes Drug

April 13, 2015 1:20 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Investors and financial analysts are worried about this decision. Read more...

TOPICS:

Actavis, Medicines360 Announce U.S. Availability of Liletta

April 13, 2015 12:16 pm | News | Comments

Actavis plc, a leading global pharmaceutical company and leader in women's health care, and Medicines360, a nonprofit women's health pharmaceutical company, announced today that Liletta (levonorgestrel-releasing intrauterine system) 52 mg is now available in the U.S. for use by women to prevent pregnancy for up to three years.

TOPICS:

Hi-Tech Pharmaceuticals To Acquire Advanced Pharmaceuticals, Nutritionals

April 13, 2015 11:58 am | News | Comments

Hi-Tech Pharmaceuticals ("Hi-Tech"), a leading global provider of Dietary Supplements, Contract Manufacturing, Raw Material Sales, and OTC Pharmaceuticals, and Advanced Pharmaceuticals and Nutritionals ("APN"), headquartered in Guadalajara, Mexico, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire APN for an undisclosed amount. 

TOPICS:
Advertisement

California Vaccine Bill Sparks Acidic Debate

April 13, 2015 11:49 am | by Judy Lin, Associated Press | News | Comments

A California bill that would sharply limit vaccination waivers after a measles outbreak at Disneyland has generated such an acidic debate that the proposal's author was under added security this week. Read more...

TOPICS:

Investigating Overuse of Antipsychotic Drugs in Dementia Patients

April 13, 2015 11:33 am | by Rutgers University | News | Comments

Rutgers will take the lead in a three-year study that will investigate the effectiveness of federal and state initiatives to address overprescribing of antipsychotic medications for dementia patients in nursing homes. Read more...

TOPICS:

New Ebola Study Points to Potential Drug Target

April 13, 2015 11:10 am | by Washington University in St. Louis | News | Comments

Opening the door to potential treatments for the deadly Ebola virus, scientists have found that a protein made by the virus plays a role similar to that of a coat-check attendant. Read more...

TOPICS:

Medivir, Cancer Research Technology Team Up to Develop New Class of Cancer Drugs

April 13, 2015 8:33 am | News | Comments

Medivir and Cancer Research UK’s commercialization and development arm announce a partnership to develop a new class of drugs that has shown promise for treating a range of different cancers, including pancreatic cancer. Read more...

TOPICS:

Cancer Surge in China Prompts Rise of Special Patient Hotels

April 13, 2015 8:27 am | by Jack Chang, Associated Press | News | Comments

With lung, bowel and breast cancer rates surging in China, such hotels have sprouted up in big cities such as Beijing and Shanghai, part of an ad hoc response to what medical experts say is a growing health crisis challenging an unprepared medical system. Read more...

TOPICS:

Daiichi Sankyo, Terumo Apply for Manufacturing and Sales Approval of Flu Vaccine in Japan

April 13, 2015 8:22 am | News | Comments

The Vaccine is a pre-filled syringe type, intradermal influenza HA vaccine co-developed by four companies under a February 23, 2012, agreement. Read more...

TOPICS:

Research Probes New Targets for Cancer Treatment

April 13, 2015 8:22 am | by University of Aberdeen | News | Comments

New research has identified potential new targets for the treatment of certain types of cancer. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading